{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:18:50Z","timestamp":1731475130595,"version":"3.28.0"},"reference-count":18,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14745","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T11:22:47Z","timestamp":1728904967000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of the CV\u2011MED regimen in treating extramedullary involvement of multiple myeloma: A case report"],"prefix":"10.3892","volume":"28","author":[{"given":"Jinjie","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"key20241112102016_b1-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bjh.17338","article-title":"Expert review on soft-tissue plasmacytomas in multiple myeloma: Definition, disease assessment and treatment considerations","volume":"194","author":"Rosi\u00f1ol","year":"2021","journal-title":"Br J Haematol"},{"key":"key20241112102016_b2-ol-28-6-14745","first-page":"8","article-title":"Consensus for the diagnosis and management of extramedullary plasmacytoma in China (2024)","volume":"45","author":"Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association; Chinese Myeloma Committee-Chinese Hematology Association","year":"2024","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20241112102016_b3-ol-28-6-14745","first-page":"302","article-title":"Progress in diagnosis and treatment of extramedullary plasma cell tumors","volume":"15","author":"Du","year":"2020","journal-title":"J Intern Med Concepts Pract"},{"key":"key20241112102016_b4-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1182\/blood-2015-07-635383","article-title":"How I treat extramedullary myeloma","volume":"127","author":"Touzeau","year":"2016","journal-title":"Blood"},{"key":"key20241112102016_b5-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"key20241112102016_b6-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20241112102016_b7-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11899-020-00568-3","article-title":"Extramedullary disease in multiple myeloma","volume":"15","author":"Jagosky","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"key20241112102016_b8-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"668099","DOI":"10.3389\/fonc.2021.668099","article-title":"Multiple extramedullary-bone related and\/or extramedullary extraosseous are independent poor prognostic factors in patients with newly diagnosed multiple myeloma","volume":"11","author":"He","year":"2021","journal-title":"Front Oncol"},{"key":"key20241112102016_b9-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: A systematic literature review","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J"},{"key":"key20241112102016_b10-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/10428190802657751","article-title":"The impact of extramedullary disease at presentation on the outcome of myeloma","volume":"50","author":"Wu","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"key20241112102016_b11-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.mayocp.2017.01.003","article-title":"Therapy for relapsed multiple myeloma: Guidelines from the mayo stratification for myeloma and risk-adapted therapy","volume":"92","author":"Dingli","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"key20241112102016_b12-ol-28-6-14745","first-page":"512","article-title":"A clinical study on the treatment of relapsed and refractory multiple myeloma with secondary extramedullary lesions using a liposome containing doxorubicin regimen","volume":"49","author":"Shen","year":"2022","journal-title":"Chin J Clin Oncol"},{"key":"key20241112102016_b13-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood-2020-139080","article-title":"Safety and efficacy of mitoxantrone hydrochloride liposome in patients with relapsed or refractory peripheral T-cell lymphoma and extranodal NK\/T-cell lymphoma: A prospective, single-arm, open-label, multi-center, phase I Clinical trial","volume":"136","author":"Gao","year":"2020","journal-title":"Blood"},{"key":"key20241112102016_b14-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1182\/blood-2023-188430","article-title":"Combination of mitoxantrone hydrochloride liposome with tislelizumab in patients with relapsed or refractory NK\/T cell lymphoma: A phase Ib\/I clinical trial","volume":"142","author":"Cai","year":"2023","journal-title":"Blood"},{"key":"key20241112102016_b15-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"13343","DOI":"10.1021\/acsnano.0c05194","article-title":"Liposomal delivery of mitoxantrone and a cholesteryl indoximod prodrug provides effective chemo-immunotherapy in multiple solid tumors","volume":"14","author":"Mei","year":"2020","journal-title":"ACS Nano"},{"key":"key20241112102016_b16-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"6650","DOI":"10.1182\/blood-2023-188304","article-title":"Mitoxantrone hydrochloride liposome, bortezomib, and dexamethasone- based regimen in multiple myeloma patients with extramedullary plasmacytoma: A pilot study","volume":"142","author":"Jian","year":"2023","journal-title":"Blood"},{"key":"key20241112102016_b17-ol-28-6-14745","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/hon.3088","article-title":"Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy","volume":"41","author":"Cao","year":"2023","journal-title":"Hematol Oncol"},{"key":"key20241112102016_b18-ol-28-6-14745","first-page":"463","article-title":"Successful treatment of one case with relapsed refractory multiple myeloma by chidamide in combination with bortezomib and dexamethasone","volume":"37","author":"Wang","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:20:31Z","timestamp":1731399631000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,10,14]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14745","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"article-number":"612"}}